15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering YCBD, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. The rating mix has stayed broadly stable, with Buy-side ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.10 next quarter toward $-0.37 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to YCBD.
12-MONTH PRICE TARGET
—
Average analyst target vs $0.53 current
Highest Target—
Average Target—
Lowest Target—
YCBD analyst recommendation trends
86420
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Strong BuyBuyHoldSellStrong Sell
RATING
MAR
APR
MAY
JUN
JUL
AUG
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
0
Hold
0
0
0
0
0
1
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Aug, 0 of 1 firms rate YCBD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
YCBD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.10
Range $-0.10 – $-0.10 · 1 analysts · +150% YoY
Next period, 1 analysts expect YCBD to earn $-0.10 a share (range $-0.10 – $-0.10), versus $-0.04 a year earlier. Full-year consensus is $-0.33, growing to $-0.37 the year after.
REVENUE · NEXT QUARTER
$5.6M
Range $5.6M – $5.6M · 1 analysts · +12% YoY
Revenue is expected to reach $5.6M (range $5.6M – $5.6M), +12.0% year-over-year. Full-year consensus is $21.9M, rising to $22.9M next year.
Top analysts covering YCBD
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on YCBD.
#1
Anthony Vendetti
Maxim Group · Rank #350
Buy
$2.00+277.4% to target
Overall win rate
29%
+ Follow
#2
TM
Tom McGovern
Maxim Group
Buy
$2.00+277.4% to target
Coverage
—
+ Follow
YCBD stock forecast FAQ
Is YCBD stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover YCBD?+
1 analysts have an active rating on YCBD.
Who is the most accurate analyst covering YCBD?+
Among analysts who currently cover YCBD, Anthony Vendetti of Maxim Group has the strongest overall Quantellect track record (Rank #350). Their current call is Buy with a $2.00 target.
What is YCBD's projected EPS for next quarter?+
The consensus estimate is $-0.10 per share (range $-0.10 – $-0.10) across 1 analysts. Full-year EPS is projected at $-0.33, rising to $-0.37 the following year.
How much revenue is YCBD expected to report next quarter?+
Consensus revenue is $5.6M (range $5.6M – $5.6M). Full-year revenue is projected at $21.9M, growing to $22.9M next year.
Have analysts been upgrading or downgrading YCBD lately?+
As of Aug, 0 of 1 firms rate YCBD a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their YCBD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
